These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 25721950)

  • 1. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
    McGuire A; Brown JA; Kerin MJ
    Cancer Metastasis Rev; 2015 Mar; 34(1):145-55. PubMed ID: 25721950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
    BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
    Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
    Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of micrornas in molecular genetic breast cancer subtypes.
    Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
    Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
    Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
    van Schooneveld E; Wildiers H; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
    Breast Cancer Res; 2015 Feb; 17():21. PubMed ID: 25849621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
    Madhavan D; Peng C; Wallwiener M; Zucknick M; Nees J; Schott S; Rudolph A; Riethdorf S; Trumpp A; Pantel K; Sohn C; Chang-Claude J; Schneeweiss A; Burwinkel B
    Carcinogenesis; 2016 May; 37(5):461-70. PubMed ID: 26785733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.
    Kashyap D; Kaur H
    Life Sci; 2020 Apr; 246():117417. PubMed ID: 32044304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling.
    Hua L; Zhou P; Li L; Liu H; Yang Z
    J Theor Biol; 2013 Aug; 331():1-11. PubMed ID: 23619378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction.
    Nassar FJ; Nasr R; Talhouk R
    Pharmacol Ther; 2017 Apr; 172():34-49. PubMed ID: 27916656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer.
    Zubor P; Kubatka P; Dankova Z; Gondova A; Kajo K; Hatok J; Samec M; Jagelkova M; Krivus S; Holubekova V; Bujnak J; Laucekova Z; Zelinova K; Stastny I; Nachajova M; Danko J; Golubnitschaja O
    Future Oncol; 2018 Aug; 14(18):1847-1867. PubMed ID: 30019928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability.
    Naser Al Deen N; Nassar F; Nasr R; Talhouk R
    Adv Exp Med Biol; 2019; 1152():335-364. PubMed ID: 31456193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
    Swellam M; Ramadan A; El-Hussieny EA; Bakr NM; Hassan NM; Sobeih ME; EzzElArab LR
    J Cell Biochem; 2019 Aug; 120(8):12321-12330. PubMed ID: 30825229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
    Bertoli G; Cava C; Castiglioni I
    Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
    Sherafatian M
    Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
    Wu X; Somlo G; Yu Y; Palomares MR; Li AX; Zhou W; Chow A; Yen Y; Rossi JJ; Gao H; Wang J; Yuan YC; Frankel P; Li S; Ashing-Giwa KT; Sun G; Wang Y; Smith R; Robinson K; Ren X; Wang SE
    J Transl Med; 2012 Mar; 10():42. PubMed ID: 22400902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease.
    Inns J; James V
    Breast; 2015 Aug; 24(4):364-9. PubMed ID: 25957467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.